Pharmaxis Ltd

Pharmaxis Ltdverified

PXS.AX

Price:

$0.028

Market Cap:

$20.23M

Pharmaxis Ltd engages in the research, development, and commercialization of healthcare products for the treatment of fibrotic and inflammatory diseases worldwide. The company operates through two segments, Mannitol Respiratory Business and New Drug Development. It offers Bronchitol, an inhaled dry powder for the treatment of cystic fibrosis; and Aridol, an airways inflammation test that is used to identify twitchy or hyper-responsive airways, as well as to assist in diagnosing and managing asthma. The company's product pipeline consists of oral pan-lysyl oxidase inhibitors (LOX) targeting myelofibrosis and other cancers; topical pan-LOX inhibitors targeting skin scarring after events, such ...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2003-11-09

Stock Exchange

ASX

Ticker

PXS.AX

The PE Ratio as of January 2025 (TTM) for Pharmaxis Ltd (PXS.AX) is -1.40

According to Pharmaxis Ltd’s latest financial reports and current stock price. The company's current PE Ratio is -1.40. This represents a change of -31.00% compared to the average of -2.03 of the last 4 quarters.

Pharmaxis Ltd (PXS.AX) Historical PE Ratio (quarterly & annually)

How has PXS.AX PE Ratio performed in the past?

The mean historical PE Ratio of Pharmaxis Ltd over the last ten years is -3.11. The current -1.40 PE Ratio has changed 4.40% with respect to the historical average. Over the past ten years (40 quarters), PXS.AX's PE Ratio was at its highest in in the March 2018 quarter at 49.23. The PE Ratio was at its lowest in in the December 2015 quarter at -6.93.

Quarterly (TTM)
Annual

Average

-3.11

Median

-3.57

Minimum

-18.90

Maximum

15.42

Pharmaxis Ltd (PXS.AX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Pharmaxis Ltd PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 553.17%

Maximum Annual PE Ratio = 15.42

Minimum Annual Increase = -1042.86%

Minimum Annual PE Ratio = -18.90

Quarterly (TTM)
Annual
YearPE RatioChange
2023-2.83-85.04%
2022-18.9054.85%
2021-12.20553.17%
2020-1.87-61.16%
2019-4.81-131.21%
201815.42-457.67%
2017-4.31-12.10%
2016-4.90-232.39%
20153.70-1042.86%
2014-0.39-60.37%

Pharmaxis Ltd (PXS.AX) Average PE Ratio

How has PXS.AX PE Ratio performed in the past?

The current PE Ratio of Pharmaxis Ltd (PXS.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-11.31

5-year avg

-8.12

10-year avg

-3.11

Pharmaxis Ltd (PXS.AX) PE Ratio vs. Peers

How is PXS.AX’s PE Ratio compared to its peers?

Pharmaxis Ltd’s PE Ratio is greater than Starpharma Holdings Limited (-5.50), greater than Acrux Limited (-1.65), less than Bionomics Limited (-0.30), greater than PYC Therapeutics Limited (-138.70), less than Neuren Pharmaceuticals Limited (12.96),

Build a custom stock screener for Pharmaxis Ltd (PXS.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharmaxis Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pharmaxis Ltd (PXS.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pharmaxis Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Pharmaxis Ltd's PE Ratio?

How is the PE Ratio calculated for Pharmaxis Ltd (PXS.AX)?

What is the highest PE Ratio for Pharmaxis Ltd (PXS.AX)?

What is the 3-year average PE Ratio for Pharmaxis Ltd (PXS.AX)?

What is the 5-year average PE Ratio for Pharmaxis Ltd (PXS.AX)?

How does the current PE Ratio for Pharmaxis Ltd (PXS.AX) compare to its historical average?